mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
about
Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?Leptin and its cardiovascular effects: Focus on angiogenesisA-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophyNitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.Cardiac Dysfunction Induced by Obesity Is Not Related to β-Adrenergic System Impairment at the Receptor-Signalling Pathway.Neuroendocrine and cardiac metabolic dysfunction and NLRP3 inflammasome activation in adipose tissue and pancreas following chronic spinal cord injury in the mouse.Leptin Attenuates the Contractile Function of Adult Rat Cardiomyocytes Involved in Oxidative Stress and Autophagy.Adipokines and the cardiovascular system: mechanisms mediating health and disease.Molecular mechanisms of asymmetric division in oocytes.The potential contribution of circulating and locally produced leptin to cardiac hypertrophy and failure.Inhibition of Receptor Interacting Protein Kinases Attenuates Cardiomyocyte Hypertrophy Induced by Palmitic Acid.ROCKing the JAKs.Prolonged leptin treatment increases transient outward K⁺ current via upregulation of Kv4.2 and Kv4.3 channel subunits in adult rat ventricular myocytes.Sleeve Gastrectomy Decreases Body Weight, Whole-Body Adiposity, and Blood Pressure Even in Aged Diet-Induced Obese Rats.Rapamycin inhibits epithelial-to-mesenchymal transition of peritoneal mesothelium cells through regulation of Rho GTPases.
P2860
Q26785013-6ABECA3C-11CC-406D-AE8A-350F59F1B10EQ27000027-08B79DB5-1953-47E9-933C-9875FA104473Q28570967-8C06F1AC-7BE0-461D-930D-152291E6A61DQ34233761-BC9377B6-8EBD-438C-AD8E-D5750B6461B4Q35782026-D519FF7B-CA70-4C0C-ACD3-77065DAABACCQ37212058-447A5A28-96FE-4298-8E0E-2011AA267FD9Q37448665-BBC078B2-26BF-422E-A1FE-283864EC5F7FQ38014474-67AEED42-F734-4AAC-A69D-E0FB087E0950Q38114234-6DE03AF3-F0D2-4D11-9C66-6A18944C8014Q38151769-2958052A-1368-4E69-BE15-B1679A1081ABQ38779902-61DAADE9-81F0-479D-97DF-12B407D887C7Q42610562-98401B4E-196A-42F8-BD5A-F5B27DA6FE74Q44703069-699D2596-9226-4B4B-A56D-319D741B8151Q47356519-6B219613-CF7F-4BA4-9B7A-ECBE141A75B0Q53119226-78D04861-6AC9-4C8E-A64D-2AEF96517675
P2860
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
description
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/06/01)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/06/01)
@nl
наукова стаття, опублікована в червні 2011
@uk
مقالة علمية (نشرت في يونيو 2011)
@ar
name
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@ast
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@en
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@nl
type
label
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@ast
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@en
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@nl
prefLabel
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@ast
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@en
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@nl
P2093
P2860
P1476
mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy
@en
P2093
J Craig Hunter
Morris Karmazyn
Sabzali Javadov
P2860
P2888
P304
P356
10.1007/S11010-011-0744-2
P50
P577
2011-02-13T00:00:00Z
P6179
1030202400